Проверяемый текст
Никитин, Алексей Эдуардович; Нарушения ритма и проводимости сердца у больных с коронарогенным поражением миокарда: клинические и морфофункциональные особенности, возможности фармакологической коррекции средствами базисной терапии (Диссертация 2003)
[стр. 117]

117.
Braunwald E.
Heart disease: a textbook of cardiovascular medicine / Ed.
E.
Braunwald.
6 ed.
Philadelphia.: «Sounders», 2001.
1876 p.
118.
Breithardt G., Borggrefe M., Karbenn U.
Clinical significance and limitations of ventricular late potentials.
In: Lethal arrhytmias resulting from miocardial ischemia and infarction.
Eds.
MR Rosen, I Palti.
Boston.
1989.
P.
254-256.
119.
Breithardt G., Cain M.E., El-Sherif N., et al.
Standards for analysis of ventricular late potentials using high-resolution or signal averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, the American College of Cardiology // Europ.
Heart J.
1991.
Vol.
12.
P.
473-480.
120.
Buckingham T.A., Greenwalt T., Lingle A., et al.
In anterior myocardial infarction, frequency domain is better than time-domain analysis of the signal averaged ECG for identifying patients at risk for sustained ventricular tachycardia.
PACE.
1992.
Vol.
15(11, Pt.
1).
P.
1681-1687.
121.
Camm A.
J., Fei Z.
Risk stratification after myocardial infarction // PACE.
1994.-Vol.
17.-P .
401 -416
122.
Campbell R.
W.
F., Murray A., Julian D.
G.
Relation of ventricular arrhythmias to ventricular fibrillation // Br.
Heart J.
1980.
Vol.
43.
P.
109114.

123.
Campbelll R.
W.
F.
ACE inhibitors and arrhythmias // Heart.
1996.
Vol.
76,Suppl.
3.
P.
79-82.

124.
Cameron A., Shwarts M.
J., Kronmal R.A.
et al.
Prevalence and significance of atrial fibrillation in coronary artery disease // Amer.
J.
Cardiol.
1988.
Vol.
61, №
10.
P.
401-416.
125.
Capucci A., Villani G.Q., Aschieri D.
et al.
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation // Eur.
Heart J.
2000.
Vol.21.
№1.
P.66-73.
[стр. 319]

ш ЗИТ ' s .
v • _ ’ л " ' • s * * V 4 V;vV-$? 4 V V S r •a.
• a • • ' .
К ' Л * .
' " * .
•.: p j ^ t i .
' a* M s .
r j ; .
* .
.
.
; • .
<1 • I • V , Ф, i t a d V ' v 1' ' r.
■ у * / -: > г " 4 ' .< / * ■ .
, * i • „ * • .
4 i \ >• T'’-i 'л '■ * .
■••' ■,■■>■■■ £ ■ ' ■ .
.
■ ■ ■ ■ ' ■ .
.
r .
' \ .
' ■ • • • ' ; • .
Л • S 1 o • • ‘Л: ■:'.
••'; ' •'<> :v л -: .-•' '•:' •V ' .
a * I V P W .
, 1 * 4 .
.
.
* « .
.
* .
*1 V S ' '*• ф \ M ; ■ ■ ' ! ■ ■ > ■ ' : / .
• ' ■ ■'■• ■ S : ' ■ • ■ ■ ' • ■ V » ' " ' л ; ' л Т l .
.
I » .
.
•• •> : B V * 4 6 f г Т ' .
^ .
.
.
.
<■■ v J ? v ' :,.
■':" ч,*•-\ •,’i.л •-, **v**sь • v r .
.
.
• • • • • • • .
.
.
• ■• •■■■■■>.
^-^4# •’ : ** '•* ’ *• •••' • ■ ■ ’.
• Av&v v ' : , .
• • • ' ? ■ .
• .
' * ? j v v » r " ’ r .
* ; v • • • • ' .
* .
• .
wr•a ‘ r : I .
v 3 :• • '; ' Ш у '•-■■■■■■' k r v : ' .
‘ .
/ V .
-• г : • *•! * 4 L r t • • .
* a I • .
1997.-V ol.
349.-P .
675-681.
CaliffR.
M., Harrelson-Woodlief, L„ Topol E.
J.
Left-ventricular ejection frac tion may not be useful as an end point of thrombolytic therapy comparative trials // Circulation.
-1990.
Vol.
82.
P.
1847-1852.
162.
Callans D.J., Josephson M.E.
Ventricular tachycardias in the setting of coronary artery disease.
In Zipes D.P., Jalife J.
(eds): Cardiac Electrophysiology: From Cell to Bedside.
2nd ed.
Philadelphia.: «WB Saunders», 1994.
732 p.
163.
Cameron A., Shwarts M.
J., Kronmal R.A.
et al.
Prevalence and significance of atrial fibrillation in coronary artery disease // Amer.
J.
Cardiol.
1988.
Vol.
61, №
P.
401-416.
164.
Camm A.
J., Fei Z.
Risk stratification after myocardial infarction // PACE 1994.-V ol.
17.-P .
401-416
165.
Campbell R.
W.
F., Murray A., Julian D.
G.
Relation of ventricular arrhythmias to ventricular fibrillation // Br.
Heart J.
1980.
Vol.
43.
P.
109-114.

166.
Campbelll R.
W.
F.
ACE inhibitors and arrhythmias // Heart.
1996.
Vol.
76, Suppl.
3.
P.
79-82.

167.
Campbelll R.
W.
F., Murray A., Julian, D.
G.
Ventricular arrhythmias in first 12 hours of acute myocardial infarction: Natural history study // Br.
Heart J.
1981.
Vol.
46.-P .
351-356.
168.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators.
Preliminary report: Effect ofencainide and flecaintun mortality in a randomized trial of arrhythmia suppression after myocardial infarction // N.
Eng.
J.
Med.1989.
Vol.
321.
P.
406-412.
169.
Carre F.
Physiopathology of exercise-induced arrhythmias // Rev.
Prat.
-2001.
Vol.
51, Suppl P.
S42-43 \ .
.
' * * • ; c * * ' * * • .
* *.
* ; * .
*•’* • * \ i v ,rr 'iS ■’ "{'■V...I ' .
• .
i * i / .
* • # — _ .
.
* , *• i t 1 .
i j* * V * ' • * s :y:.
c * : v ’ S

[Back]